[Use of hemosorption in the treatment of patients with chronic liver diseases].
The influence of hemosorption in multimodality therapy of 71 patients with chronic liver diseases was studied. Together with clinical improvement of the health status hemosorption was followed by a decrease in the concentration of bilirubin, cholesterol and gamma-globulins, ALT activity, the level of the thymol test, IgA, IgG and CIC. The content of T-lymphocytes and their subpopulation changed very little. Hemosorption efficacy was more marked in chronic active hepatitis and at initial stages of biliary cirrhosis than at the dystrophic stage of biliary cirrhosis. The use of hemosorption in multimodality therapy of patients with chronic liver diseases contributed to faster clinical improvement, return of biochemical and immunological indices to normal.
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006464:Hemoperfusion; D006509:Hepatitis B / Q000628:therapy; D006521:Hepatitis, Chronic / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000628:therapy; D008107:Liver Diseases / Q000628:therapy*; D008297:Male; D008875:Middle Aged
Ispol'zovanie gemosorbtsii v lechenii bol'nykh khronicheskimi zabolevaniiami pecheni.